HC Wainwright Lowers Avidity Biosciences (NASDAQ:RNA) Price Target to $68.00
Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its target price reduced by research analysts at HC Wainwright from $72.00 to $68.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s target price points to a potential upside of 127.58% […]
Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its target price reduced by research analysts at HC Wainwright from $72.00 to $68.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s target price points to a potential upside of 127.58% […]
